SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2024 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Arthur Radley1/7/2024 9:55:45 AM
   of 195
 
Rarely do you find corporations sharing press releases on Sunday, and when they do, it is normally bad news. However, AKYA has released three separate PRs today where the highlights are the following:
• Preliminary 4thQ revenue YOY shows a 20% growth.
• 4thQ Revenue is their highest-ever.
• Signed partnership deal with Thermo Fisher
• Operating Cash Flow Is Currently Expected to Break Even by the end of 2024.
2024 is developing into an exciting year for the potential of AKOYA.

News Releases | Akoya Biosciences, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext